Professor Mittelman and Professor van de Loosdrecht will review current patient management and key considerations in higher-risk MDS, and explore the latest data from ASCO and EHA 2021.

TOPIC COVERED

Investigational medicines will be discussed at this meeting.

WHO SHOULD ATTEND?

This meeting is for healthcare professionals with an interest in higher-risk MDS based in Europe and Canada only.

SPEAKERS

• Professor Moshe Mittelman (Tel Aviv Sourasky Medical Center)
• Professor Arjan van de Loosdrecht (Amsterdam UMC)

Log in to this live webinar to discuss higher-risk MDS with experts in the field via interactive presentations and an audience Q&A.
This meeting is for healthcare professionals in Europe and Canada only, and has been organised and sponsored by Takeda Pharmaceuticals International AG. Participants will need to register and provide details regarding their affiliation ahead of the event. Participants will access the meeting via a password protected microsite.

For more information, please contact: [email protected]